§ BIOTECHNOLOGY
USD · BiotechnologyOLMA
OLEMA PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 1.99
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
100 increased/new, 67 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 4.11 | EPS (TTM) | -2.02 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 10.4M | 0.0% | +107% |
| Paradigm Biocapital Advisors LP | 8.0M | 2.4% | +6% |
| Bain Capital Life Sciences Investors, LLC | 7.5M | 10.0% | −12% |
| JANUS HENDERSON GROUP PLC | 7.1M | n/a | +6% |
| BlackRock, Inc. | 5.7M | 0.0% | +2% |
| BVF INC/IL | 5.3M | 2.5% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for OLMA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER88.6% · 0 holders
OTHER6.4% · 133 holders
QUALITY / COMPOUNDER2.9% · 19 holders
DEALER / BANK0.8% · 22 holders
PASSIVE / INDEX0.8% · 9 holders
TACTICAL / MACRO0.2% · 5 holders
SYSTEMATIC / QUANT0.1% · 4 holders
INCOME / DEFENSIVE0.0% · 9 holders
GROWTH / MOMENTUM0.0% · 1 holder
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for OLMA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention OLMA yet.